Literature DB >> 32151487

Taipei consensus on integrative traditional Chinese and Western Medicine.

Hung-Chi Lue1, Yi-Chang Su2, Sunny Jui-Shan Lin3, Yi-Chia Huang4, Yung-Hsien Chang5, I-Hsin Lin6, Sze-Piao Yang7.   

Abstract

BACKGROUND: Traditional Chinese medicine and western medicine have coexisted since 1958 in Taiwan. Integrative traditional Chinese and western medicine (TC&WM) remains to be studied and promoted. In response to the documentary report of WHO Traditional Medicine Strategy 2002-2005, the present study was planned and carried out.
METHODS: During 2004-2008, 19 integrative TC&WM dialogue forums were held, in which 219 TC&WM scholars and professionals participated by invitation. The proceedings of the forums in Chinese were published. A study team was organized in 2009 to collect the consensus opinions, utilizing a Delphi method. The opinions collected were discussed in an international TC&WM forum held on November 1, 2014.
RESULTS: The opinions of TC&WM experts and professionals on the integrative issues and values were quite divergent. Of the 39 integrative issues, 34 (87.8%) reached consensus, agreeing that WM is excellent in the diagnosis and treatment of diseases/disorders, yet is still evolving, and not perfect without defects. TCM is patient-centered, wellness-oriented, inadequate for acute, critical and life-threatening diseases, but has a complementary and alternative role to WM. Of the 44 diseases/disorders, 36 (81.8%) reached consensus, worthy for integrative clinical use or trials.
CONCLUSIONS: Integrative TC&WM, combining the best features of two systems, could be a most useful and advanced healthcare medicine in the future, requiring development of regulations and guidelines for the use of TCM and more rigorous efforts have to be made in clinical trials.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Complementary and alternative medicine; Consensus; Delphi method; Traditional Chinese medicine; Western medicine

Mesh:

Substances:

Year:  2020        PMID: 32151487     DOI: 10.1016/j.jfma.2020.02.005

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  2 in total

1.  Lamb's tripe extract and vitamin B12 capsule plus celecoxib reverses intestinal metaplasia and atrophy: A retrospective cohort study.

Authors:  Si-Ran Wu; Jie Liu; Li-Feng Zhang; Na Wang; Lu-Yao Zhang; Qiong Wu; Jun-Ye Liu; Yong-Quan Shi
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

2.  Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma.

Authors:  Zhouyu Ning; Yingke Zhao; Xia Yan; Yongqiang Hua; Zhiqiang Meng
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.